Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 11, Number 6—June 2005

Perspective

An Emptying Quiver: Antimicrobial Drugs and Resistance

J. Todd Weber*Comments to Author  and Patrice Courvalin†
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Institut Pasteur, Paris, France

Main Article

Figure 2

J. Todd Weber Dr. Weber is the director of the Office of Antimicrobial Resistance, National Center for Infectious Diseases, Centers for Disease Control and Prevention. He is responsible for coordinating antimicrobial resistance activities at CDC and co-chairs the federal Interagency Task Force on Antimicrobial Resistance. He works with other agencies, state governments, medical societies, and other public and private organizations to enhance antimicrobial resistance prevention and control, surve

Figure 2. J. Todd Weber Dr. Weber is the director of the Office of Antimicrobial Resistance, National Center for Infectious Diseases, Centers for Disease Control and Prevention. He is responsible for coordinating antimicrobial resistance activities at CDC and co-chairs the federal Interagency Task Force on Antimicrobial Resistance. He works with other agencies, state governments, medical societies, and other public and private organizations to enhance antimicrobial resistance prevention and control, surveillance and response, applied research, and training.

Main Article

TOP